IRIS-BVS AMI Registry
Keywords
Abstract
Dates
Last Verified: | 11/30/2017 |
First Submitted: | 02/29/2016 |
Estimated Enrollment Submitted: | 02/29/2016 |
First Posted: | 03/03/2016 |
Last Update Submitted: | 12/17/2017 |
Last Update Posted: | 12/19/2017 |
Actual Study Start Date: | 05/31/2016 |
Estimated Primary Completion Date: | 11/30/2017 |
Estimated Study Completion Date: | 11/30/2017 |
Condition or disease
Intervention/treatment
Device: acute myocardial infarction
Phase
Arm Groups
Arm | Intervention/treatment |
---|---|
acute myocardial infarction | Device: acute myocardial infarction |
Eligibility Criteria
Ages Eligible for Study | 19 Years To 19 Years |
Sexes Eligible for Study | All |
Sampling method | Non-Probability Sample |
Accepts Healthy Volunteers | Yes |
Criteria | Inclusion Criteria: - Age 19 and more - Acute myocardial infarction - Intervention with Bioresorbable Vascular Scaffold - Agreed with written informed consent form Exclusion Criteria: - Bypass graft surgery (CABG) recommended - Lesion with previous bypass graft surgery (CABG) - Severe calcification and/or severe tortuosity - Contraindication to antiplatelet agent or Inability to take dual antiplatelet therapy within 1 year - Life expectancy of 1year and under - Subjects scheduled to receive cardiac surgery or serious non-cardiac surgery - Cardiac shock |
Outcome
Primary Outcome Measures
1. Composite event [1year]
Secondary Outcome Measures
1. all death [5years]
2. cardiac death [5years]
3. myocardial infarction [5years]
4. Composite event of death or myocardial infarction [5years]
5. Composite event of cardiac death or myocardial infarction [5years]
6. Target Vessel revascularization [5years]
7. Target Lesion revascularization [5years]
8. Stent thrombosis [5years]
9. Procedural success [3days]